Transpire Bio’s Dr. Lei Mao Appointed as Board Chair of the IPAC-RS for its 2026-2028 Term

SUNRISE, Fla., August 11, 2026 (PR NEWSWIRE) — Transpire Bio Inc., an integrated, U.S.-based, clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, last week announced that Lei Mao, PhD, Transpire Bio’s Head of External Research, has been elected to the position of Board Chair of the International Pharmaceutical Aerosol Consortium on Regulation & Science […]